Internal Medicine · Wynnewood, PA
NPI
1932697505
Since 2018
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
100 E Lancaster Ave
Wynnewood, PA, 19096
Phone (484) 476-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,386
98 services
Medicare patients, 2024
31
Average age 73
Drug cost, 2024
$482K
170 prescriptions
Company payments, 2025
$1,263
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vladimir Limonnik was code G2212 (prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or), 36 times for 14 patients. In total Vladimir Limonnik billed 98 services in 9 codes, and Medicare paid $9,386.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 36 | 14 | $26.36 | $949 |
| 99215 Office E&M - Established | Office | 24 | 12 | $147.54 | $3,541 |
| 99205 Office E&M - New | Office | 13 | 13 | $180.34 | $2,344 |
Medicare prescription drug claims, 2024
In 2024, the drug Vladimir Limonnik prescribed most often to Medicare patients was Anastrozole, with 34 prescriptions and refills. In total Vladimir Limonnik wrote 170 Medicare prescriptions that cost $482K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 34 | 40 | Under 11 | $256 |
| Fulphila Pegfilgrastim-Jmdb | 18 | 18 | Under 11 | $39K |
Brand drugs: - claims; generic drugs: 96 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vladimir Limonnik $1,263 ($1,263 in general payments such as food, travel and fees) from 9 companies. The largest payer was Partner Therapeutics, Inc. with $837.
| Company | Payments | Amount |
|---|---|---|
| Partner Therapeutics, Inc. | 2 | $837 |
| Novocure Inc. NVCR | 1 | $125 |
| Astellas Pharma US Inc 4503.T | 4 | $105 |
| Tempus AI, Inc TEM | 2 | $95.47 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $25.35 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $21 |
| Array Biopharma Inc PFE | 1 | $18.82 |
| Pfizer Inc. PFE | 1 | $18.63 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $16.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.